279 related articles for article (PubMed ID: 24924124)
1. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
2. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.
Lee KS; Liu JY; Wagner KM; Pakhomova S; Dong H; Morisseau C; Fu SH; Yang J; Wang P; Ulu A; Mate CA; Nguyen LV; Hwang SH; Edin ML; Mara AA; Wulff H; Newcomer ME; Zeldin DC; Hammock BD
J Med Chem; 2014 Aug; 57(16):7016-30. PubMed ID: 25079952
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.
Wagner K; Gilda J; Yang J; Wan D; Morisseau C; Gomes AV; Hammock BD
Behav Brain Res; 2017 May; 326():69-76. PubMed ID: 28259677
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
5. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
6. Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.
Wagner K; Lee KS; Yang J; Hammock BD
Eur J Pain; 2017 Mar; 21(3):456-465. PubMed ID: 27634339
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
9. Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.
Minaz N; Razdan R; Hammock BD; Mujwar S; Goswami SK
Biomed Pharmacother; 2019 Jul; 115():108897. PubMed ID: 31102913
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models.
Wagner KM; Atone J; Hammock BD
Brain Res; 2020 Feb; 1728():146573. PubMed ID: 31790682
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.
Wagner K; Inceoglu B; Dong H; Yang J; Hwang SH; Jones P; Morisseau C; Hammock BD
Eur J Pharmacol; 2013 Jan; 700(1-3):93-101. PubMed ID: 23276668
[TBL] [Abstract][Full Text] [Related]
12. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.
Guedes AGP; Aristizabal F; Sole A; Adedeji A; Brosnan R; Knych H; Yang J; Hwang SH; Morisseau C; Hammock BD
J Vet Pharmacol Ther; 2018 Apr; 41(2):230-238. PubMed ID: 29067696
[TBL] [Abstract][Full Text] [Related]
15. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.
Chen SR; Samoriski G; Pan HL
Neuropharmacology; 2009 Aug; 57(2):121-6. PubMed ID: 19422840
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
19. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.
Wan X; Fujita Y; Chang L; Wei Y; Ma L; Wuyun G; Pu Y; Hammock BD; Hashimoto K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):412-416. PubMed ID: 32896112
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]